Venom (VENOM) is currently priced at $0.222301, reflecting a minor 24-hour decline of -0.74693%. The trading range has been tight, with a daily high of $0.232265 and a low of $0.221428, indicating market consolidation around this price level.

The volume stands at 2,193,539, translating to a low market activity reflected by a volume-to-market cap ratio of 0.47%. Moving averages are predominantly bearish, with the shorter-term 8 SMA at $0.2230 showing a decrease of -0.30%, while the longer-term 144 SMA at $0.2268 has a larger decline of -2.00%, highlighting downward momentum.

The 1-hour RSI is at a low 28, indicating that VENOM is currently oversold in the short term, which may suggest a potential reversal or bounce in price. Conversely, the 7-day RSI is at 51, suggesting neutral market conditions, while the 14-day and 30-day price changes of 29.60% and 70.92% respectively indicate strong upward momentum over those periods.

Despite the current minor pullback, VENOM has shown substantial growth over the last month, with price appreciation of over 70%. However, the price remains significantly below its all-time high of $0.782403 reached on March 25, 2024, indicating considerable room for recovery, but also highlighting the potential for continued volatility.

Given the mixed signals from technical indicators, the current oversold condition on the hourly RSI, and the strong longer-term upward trends, a cautious approach is warranted. Therefore, the recommendation for Venom (VENOM) is a Hold rating, as potential buying opportunities could emerge if price stabilization occurs, while maintaining awareness of the broader market dynamics.